nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibutilide—KCNK6—gonad—testicular cancer	0.103	0.146	CbGeAlD
Ibutilide—KCNK6—testis—testicular cancer	0.0745	0.105	CbGeAlD
Ibutilide—KCNK1—seminal vesicle—testicular cancer	0.0634	0.0896	CbGeAlD
Ibutilide—KCNH7—testis—testicular cancer	0.0554	0.0783	CbGeAlD
Ibutilide—CACNB1—female gonad—testicular cancer	0.0441	0.0624	CbGeAlD
Ibutilide—CACNB1—testis—testicular cancer	0.0391	0.0553	CbGeAlD
Ibutilide—KCNK1—female gonad—testicular cancer	0.0372	0.0526	CbGeAlD
Ibutilide—KCNK1—testis—testicular cancer	0.033	0.0467	CbGeAlD
Ibutilide—CACNB1—lymph node—testicular cancer	0.0284	0.0401	CbGeAlD
Ibutilide—KCNJ11—female gonad—testicular cancer	0.027	0.0381	CbGeAlD
Ibutilide—CACNA2D1—female gonad—testicular cancer	0.0267	0.0378	CbGeAlD
Ibutilide—Supraventricular extrasystoles—Ifosfamide—testicular cancer	0.024	0.0822	CcSEcCtD
Ibutilide—KCNK1—lymph node—testicular cancer	0.0239	0.0338	CbGeAlD
Ibutilide—CACNA2D1—testis—testicular cancer	0.0237	0.0335	CbGeAlD
Ibutilide—KCNH2—seminal vesicle—testicular cancer	0.0233	0.0329	CbGeAlD
Ibutilide—CACNA1C—testis—testicular cancer	0.0204	0.0288	CbGeAlD
Ibutilide—KCNJ11—lymph node—testicular cancer	0.0174	0.0245	CbGeAlD
Ibutilide—CACNA2D1—lymph node—testicular cancer	0.0172	0.0243	CbGeAlD
Ibutilide—CACNA1C—lymph node—testicular cancer	0.0148	0.0209	CbGeAlD
Ibutilide—KCNH2—female gonad—testicular cancer	0.0137	0.0193	CbGeAlD
Ibutilide—KCNH2—testis—testicular cancer	0.0121	0.0171	CbGeAlD
Ibutilide—Ventricular arrhythmia—Ifosfamide—testicular cancer	0.0121	0.0414	CcSEcCtD
Ibutilide—Supraventricular extrasystoles—Epirubicin—testicular cancer	0.0106	0.0364	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Ifosfamide—testicular cancer	0.00992	0.0339	CcSEcCtD
Ibutilide—Supraventricular extrasystoles—Doxorubicin—testicular cancer	0.00985	0.0337	CcSEcCtD
Ibutilide—Sinus tachycardia—Epirubicin—testicular cancer	0.00985	0.0337	CcSEcCtD
Ibutilide—Sinus tachycardia—Doxorubicin—testicular cancer	0.00911	0.0312	CcSEcCtD
Ibutilide—Ventricular tachycardia—Ifosfamide—testicular cancer	0.00896	0.0306	CcSEcCtD
Ibutilide—KCNH2—lymph node—testicular cancer	0.00879	0.0124	CbGeAlD
Ibutilide—Bundle branch block—Epirubicin—testicular cancer	0.00786	0.0269	CcSEcCtD
Ibutilide—Bundle branch block—Doxorubicin—testicular cancer	0.00727	0.0249	CcSEcCtD
Ibutilide—Cardiac failure congestive—Cisplatin—testicular cancer	0.00618	0.0211	CcSEcCtD
Ibutilide—Cardiac failure congestive—Etoposide—testicular cancer	0.00566	0.0194	CcSEcCtD
Ibutilide—Ventricular arrhythmia—Epirubicin—testicular cancer	0.00536	0.0183	CcSEcCtD
Ibutilide—Orthostatic hypotension—Cisplatin—testicular cancer	0.00512	0.0175	CcSEcCtD
Ibutilide—Ventricular arrhythmia—Doxorubicin—testicular cancer	0.00496	0.017	CcSEcCtD
Ibutilide—Renal failure—Ifosfamide—testicular cancer	0.00493	0.0168	CcSEcCtD
Ibutilide—Hypertension—Vinblastine—testicular cancer	0.00468	0.016	CcSEcCtD
Ibutilide—Bradycardia—Ifosfamide—testicular cancer	0.00458	0.0157	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Epirubicin—testicular cancer	0.00439	0.015	CcSEcCtD
Ibutilide—Renal failure—Cisplatin—testicular cancer	0.00425	0.0145	CcSEcCtD
Ibutilide—Atrioventricular block—Epirubicin—testicular cancer	0.00409	0.014	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Doxorubicin—testicular cancer	0.00406	0.0139	CcSEcCtD
Ibutilide—Ventricular tachycardia—Epirubicin—testicular cancer	0.00397	0.0136	CcSEcCtD
Ibutilide—Bradycardia—Cisplatin—testicular cancer	0.00395	0.0135	CcSEcCtD
Ibutilide—Renal failure—Etoposide—testicular cancer	0.00389	0.0133	CcSEcCtD
Ibutilide—Atrioventricular block—Doxorubicin—testicular cancer	0.00378	0.0129	CcSEcCtD
Ibutilide—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00367	0.0125	CcSEcCtD
Ibutilide—Hypotension—Bleomycin—testicular cancer	0.00349	0.0119	CcSEcCtD
Ibutilide—Palpitations—Ifosfamide—testicular cancer	0.00346	0.0118	CcSEcCtD
Ibutilide—Hypertension—Ifosfamide—testicular cancer	0.00338	0.0116	CcSEcCtD
Ibutilide—Cardiac failure congestive—Epirubicin—testicular cancer	0.00317	0.0109	CcSEcCtD
Ibutilide—Hypotension—Ifosfamide—testicular cancer	0.00299	0.0102	CcSEcCtD
Ibutilide—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00294	0.01	CcSEcCtD
Ibutilide—Dizziness—Vinblastine—testicular cancer	0.00293	0.01	CcSEcCtD
Ibutilide—Nausea—Chlorambucil—testicular cancer	0.00287	0.00981	CcSEcCtD
Ibutilide—Headache—Vinblastine—testicular cancer	0.00277	0.00948	CcSEcCtD
Ibutilide—Loss of consciousness—Etoposide—testicular cancer	0.00272	0.0093	CcSEcCtD
Ibutilide—Tachycardia—Cisplatin—testicular cancer	0.00269	0.0092	CcSEcCtD
Ibutilide—Hypertension—Etoposide—testicular cancer	0.00267	0.00913	CcSEcCtD
Ibutilide—Nausea—Vinblastine—testicular cancer	0.00263	0.00899	CcSEcCtD
Ibutilide—Orthostatic hypotension—Epirubicin—testicular cancer	0.00263	0.00899	CcSEcCtD
Ibutilide—Hypotension—Cisplatin—testicular cancer	0.00257	0.0088	CcSEcCtD
Ibutilide—Tachycardia—Etoposide—testicular cancer	0.00246	0.00842	CcSEcCtD
Ibutilide—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00243	0.00832	CcSEcCtD
Ibutilide—Hypotension—Etoposide—testicular cancer	0.00236	0.00807	CcSEcCtD
Ibutilide—Renal failure—Methotrexate—testicular cancer	0.00233	0.00797	CcSEcCtD
Ibutilide—Nausea—Bleomycin—testicular cancer	0.00222	0.0076	CcSEcCtD
Ibutilide—Renal failure—Epirubicin—testicular cancer	0.00218	0.00746	CcSEcCtD
Ibutilide—Dizziness—Ifosfamide—testicular cancer	0.00211	0.00723	CcSEcCtD
Ibutilide—Nausea—Dactinomycin—testicular cancer	0.00207	0.00708	CcSEcCtD
Ibutilide—Bradycardia—Epirubicin—testicular cancer	0.00203	0.00693	CcSEcCtD
Ibutilide—Renal failure—Doxorubicin—testicular cancer	0.00202	0.0069	CcSEcCtD
Ibutilide—Nausea—Ifosfamide—testicular cancer	0.0019	0.00649	CcSEcCtD
Ibutilide—Bradycardia—Doxorubicin—testicular cancer	0.00188	0.00641	CcSEcCtD
Ibutilide—Dizziness—Etoposide—testicular cancer	0.00167	0.00571	CcSEcCtD
Ibutilide—Nausea—Cisplatin—testicular cancer	0.00164	0.0056	CcSEcCtD
Ibutilide—Headache—Etoposide—testicular cancer	0.00158	0.00541	CcSEcCtD
Ibutilide—Syncope—Epirubicin—testicular cancer	0.00155	0.00532	CcSEcCtD
Ibutilide—Palpitations—Epirubicin—testicular cancer	0.00153	0.00524	CcSEcCtD
Ibutilide—Loss of consciousness—Epirubicin—testicular cancer	0.00152	0.00521	CcSEcCtD
Ibutilide—Nausea—Etoposide—testicular cancer	0.0015	0.00513	CcSEcCtD
Ibutilide—Hypertension—Epirubicin—testicular cancer	0.0015	0.00512	CcSEcCtD
Ibutilide—Syncope—Doxorubicin—testicular cancer	0.00144	0.00492	CcSEcCtD
Ibutilide—Palpitations—Doxorubicin—testicular cancer	0.00142	0.00485	CcSEcCtD
Ibutilide—Hypotension—Methotrexate—testicular cancer	0.00141	0.00483	CcSEcCtD
Ibutilide—Loss of consciousness—Doxorubicin—testicular cancer	0.00141	0.00482	CcSEcCtD
Ibutilide—Shock—Epirubicin—testicular cancer	0.00139	0.00476	CcSEcCtD
Ibutilide—Hypertension—Doxorubicin—testicular cancer	0.00139	0.00474	CcSEcCtD
Ibutilide—Tachycardia—Epirubicin—testicular cancer	0.00138	0.00472	CcSEcCtD
Ibutilide—Hypotension—Epirubicin—testicular cancer	0.00132	0.00452	CcSEcCtD
Ibutilide—Shock—Doxorubicin—testicular cancer	0.00129	0.0044	CcSEcCtD
Ibutilide—Tachycardia—Doxorubicin—testicular cancer	0.00128	0.00437	CcSEcCtD
Ibutilide—Hypotension—Doxorubicin—testicular cancer	0.00122	0.00418	CcSEcCtD
Ibutilide—Dizziness—Methotrexate—testicular cancer	0.001	0.00342	CcSEcCtD
Ibutilide—Headache—Methotrexate—testicular cancer	0.000947	0.00324	CcSEcCtD
Ibutilide—Dizziness—Epirubicin—testicular cancer	0.000936	0.0032	CcSEcCtD
Ibutilide—Nausea—Methotrexate—testicular cancer	0.000898	0.00307	CcSEcCtD
Ibutilide—Headache—Epirubicin—testicular cancer	0.000886	0.00303	CcSEcCtD
Ibutilide—Dizziness—Doxorubicin—testicular cancer	0.000866	0.00296	CcSEcCtD
Ibutilide—Nausea—Epirubicin—testicular cancer	0.000841	0.00287	CcSEcCtD
Ibutilide—Headache—Doxorubicin—testicular cancer	0.00082	0.0028	CcSEcCtD
Ibutilide—Nausea—Doxorubicin—testicular cancer	0.000778	0.00266	CcSEcCtD
